Connect Biopharma Holdings Limited

NasdaqGM:CNTB Stock Report

Market Cap: US$63.0m

Connect Biopharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CNTB?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5,306,1499.6%
Institutions6,284,13311.4%
General Public8,507,60515.4%
Individual Insiders12,143,06222%
VC/PE Firms23,013,08341.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 84.6% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.3%
Panacea Venture Management Co., Ltd.
13,410,000US$15.3m11.8%31.04%
11.2%
Wubin Pan
6,197,398US$7.1m0%no data
10.7%
Zheng Wei
5,928,164US$6.8m0%no data
9.6%
Suzhou Xiangtang Venture Investment Limited
5,306,149US$6.0m0%no data
8.76%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
4,840,898US$5.5m0%0.45%
8.62%
Advantech Capital Advisors II Limited
4,762,185US$5.4m0%no data
3.85%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
2,124,605US$2.4m0%0.74%
3.79%
BML Capital Management, LLC
2,093,232US$2.4m2.45%1.27%
2.19%
LAV Investment Adviser Limited
1,212,302US$1.4m0%1.71%
0.92%
UBS O'Connor LLC
510,701US$582.2k0%0.05%
0.32%
Renaissance Technologies LLC
175,500US$200.1k-17.3%no data
0.076%
Callan Capital, LLC
41,823US$47.7k0%no data
0.061%
Keudell Morrison Wealth Management, LLC
33,450US$38.1k3.88%0.01%
0.055%
Brewin Dolphin Wealth Management Limited
30,600US$34.9k141%no data
0.051%
Geode Capital Management, LLC
27,961US$31.9k0%no data
0.036%
Commonwealth Equity Services, LLC
20,000US$22.8k0%no data
0.018%
Karen Wilson
10,000US$11.4k0%no data
0.017%
Rhumbline Advisers Ltd Partnership
9,500US$10.8k0%no data
0.014%
Steven Chan
7,500US$8.5k0%no data
0.0045%
Bg Fund Management Luxembourg S.A.
2,500US$2.8k0%no data
0.0033%
BlackRock, Inc.
1,838US$2.1k-98.2%no data
0.00022%
JPMorgan Chase & Co, Brokerage and Securities Investments
121US$138.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 19:04
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Connect Biopharma Holdings Limited is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Louise ChenCantor Fitzgerald & Co.
Ziyu HeChina International Capital Corporation Limited
Emily BodnarH.C. Wainwright & Co.